Proximal interaction networks to annotate, predict, and interrogate protein function — built on quantitative mass spectrometry.
The Wright laboratory leverages quantitative mass spectrometry platforms to probe the subcellular composition of protein complexes in preclinical models of human disease. Our goal is to understand the molecular circuitry of cellular signaling to identify the most druggable protein receptors — either to selectively activate latent cell death pathways, or to facilitate growth arrest through cellular differentiation.
Our approach annotates subcellular protein–protein interactions using proximity-labeling methods coupled with quantitative mass spectrometry.
Constructing proximity interaction networks for key regulators of cellular proliferation, cell death, and cellular differentiation — revealing how protein complexes coordinate cell-fate decisions.
Read more
Developing novel proximity-labeling enzymes to capture post-translational modifications in complex biological matrices — extending the reach of quantitative proteomics into hard-to-study regimes.
Read more
Optimizing cell biology reagents and methods to interrogate the molecular function of protein complexes — enabling reproducible, mechanism-level insight in preclinical disease models.
Read more
We welcome inquiries from prospective graduate students, postdoctoral researchers, and collaborators working at the intersection of proteomics and disease biology.